Iovanace Biotherapeutics (IOVA) PT Raised to $36 at H.C. Wainwright

February 26, 2020 7:10 AM EST Send to a Friend
H.C. Wainwright analyst Joseph Pantginis raised the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $36.00 (from $21.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login